Rhumbline Advisers Axsome Therapeutics, Inc. Call Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
350Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$519 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$500 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$423 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$188 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$178 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.49B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...